In the past two years, Takeda’s Plasma-Derived Therapies Business Unit has secured five regulatory approvals in Japan, with three products launched and a fourth expected by the end of this year. It represents meaningful progress for patients in Japan with rare and complex chronic diseases who depend on plasma-derived therapies and often have few or no alternative treatments.
The team reflected on the hurdles patients have had to overcome to manage their conditions, as they began their hike, taking the Prince Route via the Hoei Crater to the Gotemba Trail. The team reflected on the hurdles patients have had to overcome to manage their conditions, as they began their hike, taking the Prince Route via the Hoei Crater to the Gotemba Trail. They climbed more than halfway, then slept, all together side by side in a mountain hut in their sleeping bags.
Then they rose before dawn for the final ascent, to be rewarded with a view of the sunrise from the summit.
AloJapan.com